Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz… - European Journal of …, 2022 - ejhp.bmj.com
Introduction While there are no pharmacological treatments with proven efficacy for
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
[HTML][HTML] Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz… - European Journal of …, 2022 - ncbi.nlm.nih.gov
Objective This observational study aimed to compare the 90-day mortality in two cohorts of
patients when the drug was administered within the first 10 days from onset of symptoms or …
patients when the drug was administered within the first 10 days from onset of symptoms or …
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz… - … journal of hospital …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction While there are no pharmacological treatments with proven efficacy for
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
[引用][C] Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz… - European Journal …, 2021 - produccioncientifica.ucm.es
[PDF][PDF] Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz… - European Journal of …, 2021 - ejhp.bmj.com
Introduction While there are no pharmacological treatments with proven efficacy for
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19.
A García, TM FJ, SP LE, MB JA… - European Journal of …, 2021 - europepmc.org
Objective This observational study aimed to compare the 90-day mortality in two cohorts of
patients when the drug was administered within the first 10 days from onset of symptoms or …
patients when the drug was administered within the first 10 days from onset of symptoms or …
[PDF][PDF] Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz, LES Perez… - infection - researchgate.net
Introduction While there are no pharmacological treatments with proven efficacy for
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19.
A García, TM FJ, SP LE, MB JA… - European Journal of …, 2021 - europepmc.org
Objective This observational study aimed to compare the 90-day mortality in two cohorts of
patients when the drug was administered within the first 10 days from onset of symptoms or …
patients when the drug was administered within the first 10 days from onset of symptoms or …